The abnormal expression and activation of HSF1 is not only closely related to poor clinical prognosis, but is also involved in a network of pro-oncogenic events, including cancer cell proliferation, survival, apoptosis resistance, and glucose metabolism. The gene discussed is HSF1; the disease is cancer.